These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12451948)

  • 1. [The medical uncertainty--an overlooked reality].
    Lunde IM
    Lakartidningen; 2002 Oct; 99(41):4068-70. PubMed ID: 12451948
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pediatrician, his laboratory and its uncertainty].
    Boulat O
    Rev Med Suisse Romande; 2002 Dec; 122(12):645-8. PubMed ID: 12611193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer screening--benefits, harms and making an informed choice.
    Barratt AL
    Aust Fam Physician; 2006; 35(1-2):39-42. PubMed ID: 16489385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening. What documentation should be required?].
    Olsen J
    Ugeskr Laeger; 2002 Jan; 164(2):148-52. PubMed ID: 11831074
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for gestational diabetes mellitus.
    Fink K; Clark B
    Am Fam Physician; 2004 Mar; 69(5):1187-8. PubMed ID: 15023021
    [No Abstract]   [Full Text] [Related]  

  • 6. Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer.
    Loeb S; Carter HB
    Urol Oncol; 2009; 27(6):583-4. PubMed ID: 19879470
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions.
    Chen YW; Lin JS; Fong JH; Wang IK; Chou SJ; Wu CH; Lui MT; Chang CS; Kao SY
    Br J Oral Maxillofac Surg; 2007 Oct; 45(7):590-1. PubMed ID: 17081665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer screening for women 40 to 49 years of age: what is a clinician to do?
    Gemignani ML
    Obstet Gynecol; 2007 Sep; 110(3):548-9. PubMed ID: 17766597
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive value of immunodiagnostic cancer tests.
    Galen RS
    Immunol Ser; 1990; 53():3-11. PubMed ID: 2100563
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating validity of screening tests.
    Larson E
    Nurs Res; 1986; 35(3):186-8. PubMed ID: 3635057
    [No Abstract]   [Full Text] [Related]  

  • 11. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the urologist in metastatic testicular cancer.
    Einhorn LH
    J Clin Oncol; 2007 Mar; 25(9):1024-5. PubMed ID: 17261852
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cancer screening: medico-legal aspects].
    Buzzi F
    Ann Ig; 2003; 15(1):3-10. PubMed ID: 12666320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of Calprotect Phical].
    Bolann BJ; Schjøth A
    Tidsskr Nor Laegeforen; 1995 Dec; 115(30):3855. PubMed ID: 8539759
    [No Abstract]   [Full Text] [Related]  

  • 15. The physician's estimation 'alternative diagnosis is less likely than pulmonary embolism' in the Wells rule is dependent on the presence of other required items.
    Klok FA; Zidane M; Djurabi RK; Nijkeuter M; Huisman MV
    Thromb Haemost; 2008 Jan; 99(1):244-5. PubMed ID: 18217165
    [No Abstract]   [Full Text] [Related]  

  • 16. Glaucoma screening: the value is in the details.
    Mills RP
    Am J Ophthalmol; 2008 Jan; 145(1):3-4. PubMed ID: 18154749
    [No Abstract]   [Full Text] [Related]  

  • 17. Fletcher's paradox.
    Dammann O; Karmaus W
    Epidemiology; 1992 Nov; 3(6):540-2. PubMed ID: 1420523
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statistical models in screening tests (author's transl)].
    Drdková S
    Sb Lek; 1974 Oct; 76(10):283-8. PubMed ID: 4424748
    [No Abstract]   [Full Text] [Related]  

  • 19. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
    Andersen SB; Vejborg I; von Euler-Chelpin M
    Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic impact of prostate cancer screening and treatment.
    DiSantostefano RL; Lavelle JP
    N C Med J; 2006; 67(2):158-60. PubMed ID: 16752723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.